{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:43:21Z","timestamp":1760985801420,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10620-019-05745-w","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T10:50:44Z","timestamp":1564743044000},"page":"204-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Presence of Precore (C)\/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4\u00a0Years of Follow-Up"],"prefix":"10.1007","volume":"65","author":[{"given":"Shivali S.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-0901","authenticated-orcid":false,"given":"Carla S.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"5745_CR1","unstructured":"WHO|Hepatitis B factsheet. Updated July 5, 2019. \nhttps:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b\n\n. Accessed July 10, 2019."},{"key":"5745_CR2","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1128\/JVI.02127-13","volume":"87","author":"T Bian","year":"2013","unstructured":"Bian T, Yan H, Shen L, et al. Change in hepatitis B virus large surface antigen variant prevalence 13\u00a0years after implementation of a universal vaccination program in China. J Virol. 2013;87:12196\u201312206. \nhttps:\/\/doi.org\/10.1128\/JVI.02127-13\n\n.","journal-title":"J Virol"},{"key":"5745_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3851\/IMP1556","volume":"15","author":"C-G Teo","year":"2010","unstructured":"Teo C-G, Locarnini SA. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health. Antivir Ther. 2010;15:445\u2013449. \nhttps:\/\/doi.org\/10.3851\/IMP1556\n\n.","journal-title":"Antivir Ther"},{"key":"5745_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4254\/wjh.v10.i9.585","volume":"10","author":"AE Maraolo","year":"2018","unstructured":"Maraolo AE, Gentile I, Buonomo AR, et al. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol. 2018;10:585\u2013594. \nhttps:\/\/doi.org\/10.4254\/wjh.v10.i9.585\n\n.","journal-title":"World J Hepatol"},{"key":"5745_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00404-010-1366-8","volume":"283","author":"GQ Bai","year":"2011","unstructured":"Bai GQ, Li SH, Yue YF, Shi L. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection. Arch Gynecol Obstet. 2011;283:317\u2013321. \nhttps:\/\/doi.org\/10.1007\/s00404-010-1366-8\n\n.","journal-title":"Arch Gynecol Obstet"},{"key":"5745_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7150\/ijbs.10813","volume":"11","author":"Y-Y Xu","year":"2015","unstructured":"Xu Y-Y, Liu H-H, Zhong Y-W, et al. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus. Int J Biol Sci. 2015;11:266\u2013273. \nhttps:\/\/doi.org\/10.7150\/ijbs.10813\n\n.","journal-title":"Int J Biol Sci"},{"key":"5745_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00404-013-2893-x","volume":"288","author":"Q Shao","year":"2013","unstructured":"Shao Q, Zhao X, Yao Li MD. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection. Arch Gynecol Obstet. 2013;288:1257\u20131261. \nhttps:\/\/doi.org\/10.1007\/s00404-013-2893-x\n\n.","journal-title":"Arch Gynecol Obstet"},{"key":"5745_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHEP.2019.03.034","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;. \nhttps:\/\/doi.org\/10.1016\/J.JHEP.2019.03.034\n\n.","journal-title":"J Hepatol"},{"key":"5745_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.4254\/wjh.v7.i8.1086","volume":"7","author":"S Gao","year":"2015","unstructured":"Gao S, Duan Z-P, Coffin CS. Clinical relevance of hepatitis B virus variants. World J Hepatol. 2015;7:1086\u20131096. \nhttps:\/\/doi.org\/10.4254\/wjh.v7.i8.1086\n\n.","journal-title":"World J Hepatol"},{"key":"5745_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s11684-017-0597-5","volume":"11","author":"X Shi","year":"2017","unstructured":"Shi X, Wang X, Xu X, et al. Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission. Front Med. 2017;11:548\u2013553. \nhttps:\/\/doi.org\/10.1007\/s11684-017-0597-5\n\n.","journal-title":"Front Med"},{"key":"5745_CR11","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1128\/JVI.01905-08","volume":"83","author":"S Datta","year":"2009","unstructured":"Datta S, Panigrahi R, Biswas A, et al. Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation. J Virol. 2009;83:9983\u20139992. \nhttps:\/\/doi.org\/10.1128\/JVI.01905-08\n\n.","journal-title":"J Virol"},{"key":"5745_CR12","doi-asserted-by":"publisher","first-page":"e0140070","DOI":"10.1371\/journal.pone.0140070","volume":"10","author":"B Virine","year":"2015","unstructured":"Virine B, Osiowy C, Gao S, et al. Hepatitis B virus (HBV) variants in untreated and tenofovir treated chronic hepatitis B (CHB) patients during pregnancy and post-partum follow-up. PLoS ONE. 2015;10:e0140070. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0140070\n\n.","journal-title":"PLoS ONE"},{"key":"5745_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcv.2006.10.008","volume":"38","author":"MA Papadakis","year":"2007","unstructured":"Papadakis MA, Elefsiniotis IS, Vlahos G, et al. Intrauterine-transplacental transmission of hepatitis B virus (HBV) from hepatitis B e antigen negative (precore mutant, G1896A) chronic HBV infected mothers to their infants. Preliminary results of a prospective study. J Clin Virol. 2007;38:181\u2013183. \nhttps:\/\/doi.org\/10.1016\/j.jcv.2006.10.008\n\n.","journal-title":"J Clin Virol"},{"key":"5745_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jmv.23260","volume":"84","author":"P Sa-Nguanmoo","year":"2012","unstructured":"Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, et al. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case\u2013control study in Thailand. J Med Virol. 2012;84:1177\u20131185. \nhttps:\/\/doi.org\/10.1002\/jmv.23260\n\n.","journal-title":"J Med Virol"},{"key":"5745_CR15","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jgh.13338","volume":"31","author":"A Ducancelle","year":"2016","unstructured":"Ducancelle A, Pivert A, Bertrais S, et al. Different precore\/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity. J Gastroenterol Hepatol. 2016;31:1750\u20131756. \nhttps:\/\/doi.org\/10.1111\/jgh.13338\n\n.","journal-title":"J Gastroenterol Hepatol"},{"key":"5745_CR16","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1086\/515269","volume":"177","author":"M Sterneck","year":"1998","unstructured":"Sterneck M, Kalinina T, Otto S, et al. Neonatal fulminant hepatitis B: structural and functional analysis of complete hepatitis B virus genomes from mother and infant. J Infect Dis. 1998;177:1378\u20131381.","journal-title":"J Infect Dis"},{"key":"5745_CR17","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/hep.510290418","volume":"29","author":"M Friedt","year":"1999","unstructured":"Friedt M, Gerner P, Lausch E, et al. Mutations in the basic core promotor and the precore region of hepatitis b virus and their selection in children with fulminant and chronic hepatitis B. Hepatology. 1999;29:1252\u20131258. \nhttps:\/\/doi.org\/10.1002\/hep.510290418\n\n.","journal-title":"Hepatology"},{"key":"5745_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.virol.2009.02.015","volume":"387","author":"H Cheng","year":"2009","unstructured":"Cheng H, Su H, Wang S, et al. Association between genomic heterogeneity of hepatitis B virus and intrauterine infection. Virology. 2009;387:168\u2013175. \nhttps:\/\/doi.org\/10.1016\/j.virol.2009.02.015\n\n.","journal-title":"Virology"},{"key":"5745_CR19","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1111\/liv.13139","volume":"36","author":"G Samadi Kochaksaraei","year":"2016","unstructured":"Samadi Kochaksaraei G, Congly SE, Matwiy T, et al. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk. Liver Int. 2016;36:1604\u20131610. \nhttps:\/\/doi.org\/10.1111\/liv.13139\n\n.","journal-title":"Liver Int"},{"key":"5745_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.10.015","author":"KC Lau","year":"2018","unstructured":"Lau KC, Osiowy C, Coffin CS. Hepatitis B virus (HBV) genome detection and genotyping in virally suppressed patients using nested polymerase chain reaction-based Sanger sequencing. Diagn Microbiol Infect Dis. 2018;. \nhttps:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.10.015\n\n.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5745_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcv.2017.06.009","volume":"94","author":"S Gao","year":"2017","unstructured":"Gao S, Duan Z-P, Chen Y, et al. Compartmental HBV evolution and replication in liver and extrahepatic sites after nucleos\/tide analogue therapy in chronic hepatitis B carriers. J Clin Virol. 2017;94:8\u201314. \nhttps:\/\/doi.org\/10.1016\/j.jcv.2017.06.009\n\n.","journal-title":"J Clin Virol"},{"key":"5745_CR22","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jvh.12860","volume":"25","author":"KCK Lau","year":"2018","unstructured":"Lau KCK, Osiowy C, Giles E, et al. Deep sequencing shows low-level oncogenic hepatitis B virus variants persists post-liver transplant despite potent anti-HBV prophylaxis. J Viral Hepat. 2018;25:724\u2013732. \nhttps:\/\/doi.org\/10.1111\/jvh.12860\n\n.","journal-title":"J Viral Hepat"},{"key":"5745_CR23","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1099\/0022-1317-76-12-3159","volume":"76","author":"K Takahashi","year":"1995","unstructured":"Takahashi K, Aoyama K, Ohno N, et al. The precore\/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol. 1995;76:3159\u20133164. \nhttps:\/\/doi.org\/10.1099\/0022-1317-76-12-3159\n\n.","journal-title":"J Gen Virol"},{"key":"5745_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-62703-484-5_13","volume":"1030","author":"D Cai","year":"2013","unstructured":"Cai D, Nie H, Yan R, et al. A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures. Methods Mol Biol. 2013;1030:151\u2013161. \nhttps:\/\/doi.org\/10.1007\/978-1-62703-484-5_13\n\n.","journal-title":"Methods Mol Biol"},{"key":"5745_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3851\/IMP1499","volume":"15","author":"SA Locarnini","year":"2010","unstructured":"Locarnini SA, Yuen L. Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther. 2010;15:451\u2013461. \nhttps:\/\/doi.org\/10.3851\/IMP1499\n\n.","journal-title":"Antivir Ther"},{"key":"5745_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/J.JHEP.2013.02.015","volume":"59","author":"W-H Wen","year":"2013","unstructured":"Wen W-H, Chang M-H, Zhao L-L, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013;59:24\u201330. \nhttps:\/\/doi.org\/10.1016\/J.JHEP.2013.02.015\n\n.","journal-title":"J Hepatol"},{"key":"5745_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jvh.12308","volume":"22","author":"CS Coffin","year":"2015","unstructured":"Coffin CS, Osiowy C, Gao S, et al. Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases. J Viral Hepat. 2015;22:416\u2013426. \nhttps:\/\/doi.org\/10.1111\/jvh.12308\n\n.","journal-title":"J Viral Hepat"},{"key":"5745_CR28","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.4049\/jimmunol.178.6.3345","volume":"178","author":"I Guleria","year":"2007","unstructured":"Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J Immunol. 2007;178:3345\u20133351.","journal-title":"J Immunol"},{"key":"5745_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12707","author":"SS Joshi","year":"2017","unstructured":"Joshi SS, Wong D, Castillo E, et al. Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease. Am J Reprod Immunol. 2017;. \nhttps:\/\/doi.org\/10.1111\/aji.12707\n\n.","journal-title":"Am J Reprod Immunol"},{"key":"5745_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3967\/bes2019.043","volume":"32","author":"DD Wang","year":"2019","unstructured":"Wang DD, Yi LZ, Wu LN, et al. Relationship between maternal PBMC HBV cccDNA and HBV serological markers and its effect on HBV intrauterine transmission. Biomed Environ Sci. 2019;32:315\u2013323. \nhttps:\/\/doi.org\/10.3967\/bes2019.043\n\n.","journal-title":"Biomed Environ Sci"},{"key":"5745_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/cmi.2010.34","volume":"7","author":"L Koumbi","year":"2010","unstructured":"Koumbi L, Bertoletti A, Anastasiadou V, et al. Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+\/HBeAg\u2212 mothers. Cell Mol Immunol. 2010;7:454\u2013458. \nhttps:\/\/doi.org\/10.1038\/cmi.2010.34\n\n.","journal-title":"Cell Mol Immunol"},{"key":"5745_CR32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.07.012","author":"WS Mason","year":"2016","unstructured":"Mason WS, Gill US, Litwin S, et al. HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis b patients considered immune tolerant. Gastroenterology. 2016;. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2016.07.012\n\n.","journal-title":"Gastroenterology"},{"key":"5745_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3138\/canlivj.2018-0008","volume":"1","author":"CS Coffin","year":"2018","unstructured":"Coffin CS, Fung SK, Alvarez F, et al. Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Can Liver J. 2018;1:156\u2013217. \nhttps:\/\/doi.org\/10.3138\/canlivj.2018-0008\n\n.","journal-title":"Can Liver J"},{"key":"5745_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hep.25988","volume":"57","author":"T-W Wu","year":"2013","unstructured":"Wu T-W, Lin HH, Wang L-Y. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology. 2013;57:37\u201345. \nhttps:\/\/doi.org\/10.1002\/hep.25988\n\n.","journal-title":"Hepatology"},{"key":"5745_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.JINF.2019.01.002","author":"A Eilard","year":"2019","unstructured":"Eilard A, Andersson M, Ringlander J, et al. Vertically acquired occult hepatitis B virus infection may become overt after several years. J Infect. 2019;. \nhttps:\/\/doi.org\/10.1016\/J.JINF.2019.01.002\n\n.","journal-title":"J Infect"},{"key":"5745_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","volume":"32","author":"V de L\u00e9dinghen","year":"2008","unstructured":"de L\u00e9dinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol. 2008;32:58\u201367. \nhttps:\/\/doi.org\/10.1016\/S0399-8320(08)73994-0\n\n.","journal-title":"Gastroenterol Clin Biol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05745-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T09:16:18Z","timestamp":1596273378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5745"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05745-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"3 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"CS. Coffin: Investigator Initiated Research Grant\/Research Materials\u2014GSK, Gilead Sciences, Arbutus Biopharma, Bristol-Myers Squibb; Educational Grants\u2014Merck, Gilead Sciences, Janssen Inc. Advisory Board - Merck, Gilead Sciences, GSK; CTPC committee - Springbank Pharmaceuticals; Local Site PI participation in Clinical Trials\u2014Gilead Sciences, Springbank Pharmaceuticals, Transgene. Other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Calgary Conjoint Health Research Review Board in accordance with the Declaration of Helsinki (Ethics ID # REB14-1966). All subjects provided written informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}